Skip to main content
Charles Nicolette, MD, Radiology, Odessa, TX

CharlesCNicoletteMD

Radiology Odessa, TX

Physician

Dr. Nicolette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nicolette's full profile

Already have an account?

  • Office

    1417 Sweetbriar
    Odessa, TX 79761
    Phone+1 432-288-3379

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Radiology-Diagnostic, 1966 - 1969
  • OhioHealth/Riverside Methodist Hospital
    OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 1965 - 1966
  • OhioHealth/Riverside Methodist Hospital
    OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 1964 - 1965
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1964

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1969 - 2026
  • TX State Medical License
    TX State Medical License 1974 - 2026
  • MN State Medical License
    MN State Medical License 1967 - 1999
  • OH State Medical License
    OH State Medical License 1964 - 1994
  • American Board of Radiology Diagnostic Radiology

Publications & Presentations

PubMed

  • 19 citations
    The duodenum in celiac sprue.
    Charles C. Nicolette, Timothy E. Tully
    The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine. 1971-10-01

Press Mentions

  • CoImmune, Inc. To Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
    CoImmune, Inc. To Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech SummitSeptember 20th, 2021
  • CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of Directors
    CoImmune, Inc. Announces Appointment of Ed Baracchini to Board of DirectorsFebruary 24th, 2021
  • Chimeric Antigen Receptor (CAR)-Modified Cytokine Induced Killer Cell (CAR-CIK) Technology Featured at ASH
    Chimeric Antigen Receptor (CAR)-Modified Cytokine Induced Killer Cell (CAR-CIK) Technology Featured at ASHDecember 16th, 2020
  • Join now to see all